Scholars Central

Conference abstractPublished 24 Jun 2014

Human fetal liver progenitor cell transplantation: A potential bridging therapy to liver transplantation in patients with end-stage liver disease

Authors: Giada Pietrosi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T hLiver transplantation is currently the only therapeutic option for patients with end stage liver disease, but its applicability is limited because of the widening gap between the number of transplant candidates and available organs. Therefore, the development of new and successful treatments for liver failure could have a significant clinical and social impact. Over the last few years, ISMETT, in collaboration with University of Pittsburgh, has developed an efficient protocol of human fetal liver cell isolation, from the late second trimester, based on a 5-step vascular perfusion method. This method guarantees high cell viabilities and reduces the exposure of the tissue to collagenase 4-fold. It was observed that fetal hepatocytes obtained from livers of different gestational age perform liver-specific functions (albumin secretion, urea synthesis and G6Pase activity) at levels comparable to thoseof their adult counterparts, and cryopreservation had only a minor impact on fetalliver cell viability and function. The mean percentage of viability of thawed cells stored up to 1 year in liquid nitrogen was approximately 70%, and the attachment efficiency, as well as the tested hepatic functions, was not impaired. We also moved to clinical application by performing a phase I-II clinical study on intra splenic infusion of non-sorted, fresh, fetal liver cells in a small group of patients with end stage liver disease. The procedure was found to be a safe bridging therapy to liver transplantation, and a preliminary positive effect on clinical scores and on encephalopathy also emerged from this study

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Giada Pietrosi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels